Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids

<b><i>Background</i></b>: Selective progesterone receptor modulator ulipristal acetate (UPA) is a drug used in management of symptomatic myomas. It was observed that the response to UPA treatment in uterine myomas varied amongst patients. An attempt was thus made at establish...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Iwona Szydłowska, Aleksandra Marciniak, Jolanta Nawrocka-Rutkowska, Aleksandra Rył, Andrzej Starczewski
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-01-01
Col·lecció:International Journal of Environmental Research and Public Health
Matèries:
uterine myomas
ulipristal acetate
predictive factors
Accés en línia:https://www.mdpi.com/1660-4601/17/3/798
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars